Matt Britz (@mattbritz) profile picture

Biotech CEO, working on a great cancer drug! Check out Saros Tx! (Opinions are my own)

Boston, MA
Joined April 2010
Photo by Matt Britz (@mattbritz)Photo by Matt Britz (@mattbritz)Photo by Matt Britz (@mattbritz)Photo by Matt Britz (@mattbritz)Photo by Matt Britz (@mattbritz)Photo by Matt Britz (@mattbritz)Photo by Matt Britz (@mattbritz)
Matt Britz retweeted
How specific are therapeutic monoclonal antibodies, really? In our new paper, @Yile_Dai led a collaboration with Adimab to profile 174 FDA-approved and clinical-stage mAbs against 6,172 human extracellular proteins. What we found surprised us.🧵 sciencedirect.com/science/ar…
16
117
8
406
58,584
Excited to share our upcoming poster presentation at #ASCO24 @ASCO where we will present a confirmed complete response in a patient with Anaplastic #Thyroid Cancer with our autologous CAR T therapy AIC100. businesswire.com/news/home/2…
2
2
4
230
Proud to announce that Affy has achieved a complete response in an anaplastic thyroid cancer patient in our Phase 1 trial with AIC100, our autologous CAR T cell product #ASCO24 tinyurl.com/ysnmzddb
2
4
414
From Phillips Beach in Swampscott! 📸 Jackie D
14
7
1
215
12,205
Happy CD3/CD28 T Cell Activation Day! 3/28
1
13
3
112
5,773
I have news…. Also, so happy to have Pete join the Affy team!
AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC dlvr.it/T4HqRj
6
113
The Best Oncology R&D Advance Award has been handed to AffyImmune Therapeutics’ (@affyimmune) AIC100 ICAM-1 targeting CAR T cell therapy. Well done on your win! ow.ly/Gy8T50Q8nKI #ScripAwards #ScripAwards2023 #Citeline
3
9
509
Eisai And Eli Lilly Triumph At The 19th Annual Scrip Awards bit.ly/40GDOie #PharmaScrip
1
2
308
We are thrilled to announce that AffyImmune Therapeutics was selected as the winner of the Best Oncology R&D Advance Award last night at the 2023 Scrip Awards! Congratulations to our full team and thank you all for your hard work and dedication to our mission. #Oncology #CARTcell
1
3
93
Join Chief Operating Officer @mattbritz today at 5:00 pm PT in the Rentschler ATMP Ballroom for his presentation at @alliancerm’s #CGMesa23! The presentation will be available to virtual attendees on the event livestream – see below link to register: meetingonthemesa.com/
1
4
121
AffyImmune Therapeutics is excited to share that it’s recently named as one of the Best Oncology R&D Advances as a 2023 finalist for the @Citeline Scrip Awards! The winner will be announced in London on November 16, 2023. citeline.com/awards/scripawa… #oncology #CARTcell
2
1
8
279
Live from New York, it's... AffyImmune! Our friends at @tryramp gave us a boost in Times Square, featuring a tweet by @Cornell_CTL about our clinical data from #ASCO23 Thanks to Ramp for the surprise and to our partners helping deliver AIC100 to patients in our clinical trial!
2
3
3
23
2,587
Jan Skvarka took Trillium Therapeutics from a $16 million market capitalisation to a $2.26 billion acquisition by Pfizer in only 2 years and in the midst of the pandemic. The story and 6 lessons on biotech strategy, culture, and success. 🧵
7
57
15
287
114,643
We are encouraged by positive safety & early efficacy results from our Phase 1 study of AIC100 CAR T cells in anaplastic & advanced thyroid cancers to be presented at #ASCO23, with an unprecedented partial response for a patient with ATC! #CARtcelltherapy #thyroidcancer #biotech
1
3
161
#ASCO23 5:00PM ET today: Majority of abstracts released on meetings.asco.org (Late-breaking Abstracts will be released on a rolling basis during the meeting)
7
1
21
8,355
PASTA
12
82
92
506
177,656
Kite acquired Tmunity - deal closed last week. Did you know they paid approx $300 million for the shares they didn't already own? #cartcells
1
1
360
Matt Britz retweeted
Exciting #IO360nyc keynote by Dr. @MarcelaMaus of MGH on #solidtumors & #CART. Loss of IFNyR signaling in solid tumors can drive resistance and CAR-T cytotoxicity suggesting a “crucial role of IFNyR in stabilizing and enhancing solid tumor CAR T cell interactions.”#CancerResearch
1
3
314
In with a bang, out with a whimper. My quick take on Tmunity, via @evaluatevantage evaluate.com/vantage/article… $GILD $NVS $ACLX
2
1
5
3,955